Skip to main content
. 2012 Mar 16;61(10):1781–1790. doi: 10.1007/s00262-012-1226-4

Fig. 2.

Fig. 2

Performance status (PS) and tumor marker levels from staring time of immunotherapy to death. Illustrations of the disease course on 4 representative patients, and a summarizing table of PS on 72 cancer patients